Literature DB >> 29923079

Clinical pathways in gastric cancer care.

Maria Bencivenga1, Ilaria Palla2, Lorenzo Scorsone3, Alberto Bortolami4, Valentina Mengardo3, Michele Pavarana5, Giuseppe Turchetti2, Giovanni de Manzoni3.   

Abstract

The diagnostic-therapeutic pathways (DTPs) are emerging as useful instruments for clinical management of complex diseases as gastric cancer, whose treatment is challenging and requires a multidisciplinary approach. However, the DPTs of patients with gastric cancer are still not defined yet. The aim of this study was to define the optimal DPT to be applied for patients with gastric cancer in the Veneto region. Rather than defining the ideal DTPs a priori, we conducted a preliminary research by analyzing the differences in the actual DPTs for patients with gastric cancer among different hospitals (hub and spokes) in Veneto. Then, the final DPT was elaborated based on the current available best clinical evidences; however, also the areas of homogeneity among the actual DPTs of the included centers as well as the critical issues that had emerged by our preliminary analysis were taken into account for pathway design. High heterogeneity in actual DTPs of patients with gastric cancer was observed among the analyzed centres. Moreover, some of the major criticisms have been found at crucial points of the current pathways. Based on these data, a reference path that is applicable to the whole-regional health network was constructed. The reference DTP is focused on multidisciplinary team management of patients with gastric cancer. Clinical pathways are essential tools to properly manage complex diseases such as gastric cancer. As such, more efforts should be done to implement their use.

Entities:  

Keywords:  Critical issues; Diagnostic–therapeutic pathways; Gastric cancer; Implementation areas; Reference pathway

Mesh:

Year:  2018        PMID: 29923079     DOI: 10.1007/s13304-018-0544-2

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  7 in total

1.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A Okines; M Verheij; W Allum; D Cunningham; A Cervantes
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Role of clinical pathways in health care provision: Focus on cancer treatment.

Authors:  Eugene D Kreys; Jim M Koeller
Journal:  Am J Health Syst Pharm       Date:  2013-06-15       Impact factor: 2.637

3.  Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  T Waddell; M Verheij; W Allum; D Cunningham; A Cervantes; D Arnold
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

4.  Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).

Authors:  M Messager; W de Steur; P G Boelens; L S Jensen; C Mariette; J V Reynolds; J Osorio; M Pera; J Johansson; P Kołodziejczyk; F Roviello; G De Manzoni; S P Mönig; W H Allum
Journal:  Eur J Surg Oncol       Date:  2016-02-06       Impact factor: 4.424

Review 5.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  William H Allum; Jane M Blazeby; S Michael Griffin; David Cunningham; Janusz A Jankowski; Rachel Wong
Journal:  Gut       Date:  2011-06-24       Impact factor: 23.059

6.  The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015.

Authors:  Giovanni De Manzoni; Daniele Marrelli; Gian Luca Baiocchi; Paolo Morgagni; Luca Saragoni; Maurizio Degiuli; Annibale Donini; Uberto Fumagalli; Maria Antonietta Mazzei; Fabio Pacelli; Anna Tomezzoli; Mattia Berselli; Filippo Catalano; Alberto Di Leo; Massimo Framarini; Simone Giacopuzzi; Luigina Graziosi; Alberto Marchet; Mario Marini; Carlo Milandri; Gianni Mura; Elena Orsenigo; Vittorio Quagliuolo; Stefano Rausei; Riccardo Ricci; Fausto Rosa; Giandomenico Roviello; Andrea Sansonetti; Giovanni Sgroi; Guido Alberto Massimo Tiberio; Giuseppe Verlato; Carla Vindigni; Riccardo Rosati; Franco Roviello
Journal:  Gastric Cancer       Date:  2016-06-02       Impact factor: 7.370

7.  The hub-and-spoke organization design: an avenue for serving patients well.

Authors:  James K Elrod; John L Fortenberry
Journal:  BMC Health Serv Res       Date:  2017-07-11       Impact factor: 2.655

  7 in total
  1 in total

1.  Antimicrobial Step-Down Therapy versus Conventional Antimicrobial Therapy in the Treatment of Patients with Sepsis.

Authors:  Zhuo Peng; Zequn Niu; Rui Zhang; Longfei Pan; Hui Feng; Yang Zhou; Honghong Pei
Journal:  Dis Markers       Date:  2022-08-31       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.